MiNK Therapeutics, Inc. (INKT) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

MiNK Therapeutics, Inc. (INKT) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $50.7M, listed on NASDAQ, employing roughly 23 people, carrying a beta of 0.47 to the broader market. MiNK Therapeutics, Inc. Led by Jennifer S. Buell, public since 2021-10-15.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for INKT as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →